Home » Inspire Increases Production of AzaSite in Response to Shortage
Inspire Increases Production of AzaSite in Response to Shortage
Inspire Pharmaceuticals, Inc. announced that it has been communicating with the FDA and is increasing its production of AzaSite (azithromycin ophthalmic solution) 1% in response to the manufacturing supply shortage of erythromycin ophthalmic ointment (0.5%).
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May